| # | Title | Journal | Year | Citations |
|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
| 2 | Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis | New England Journal of Medicine | 2012 | 1,493 |
| 3 | Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis | Lancet Neurology, The | 2004 | 963 |
| 4 | Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway | Brain | 2011 | 942 |
| 5 | Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution | Nature | 2019 | 853 |
| 6 | Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients | Neuroscience Letters | 1995 | 719 |
| 7 | MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome | Journal of Neuroinflammation | 2016 | 686 |
| 8 | Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine | Immunity | 2015 | 637 |
| 9 | MOG encephalomyelitis: international recommendations on diagnosis and antibody testing | Journal of Neuroinflammation | 2018 | 563 |
| 10 | Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2 | Nature Genetics | 2004 | 454 |
| 11 | Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial | Lancet, The | 2019 | 384 |
| 12 | Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial | Lancet Neurology, The | 2006 | 377 |
| 13 | Sex and gender issues in multiple sclerosis | Therapeutic Advances in Neurological Disorders | 2013 | 368 |
| 14 | Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism | Cell | 2020 | 367 |
| 15 | MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin | Journal of Neuroinflammation | 2016 | 351 |
| 16 | TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis | Nature | 2012 | 323 |
| 17 | Sensorimotor returning in complex regional pain syndrome parallels pain reduction | Annals of Neurology | 2005 | 322 |
| 18 | Reduced Basal Autophagy and Impaired Mitochondrial Dynamics Due to Loss of Parkinson's Disease-Associated Protein DJ-1 | PLoS ONE | 2010 | 319 |
| 19 | Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses | Annals of Neurology | 2016 | 315 |
| 20 | Changes of cortical motor area size during immobilization | Electroencephalography and Clinical Neurophysiology - Electromyography and Motor Control | 1995 | 312 |
| 21 | MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease | European Journal of Pharmacology | 1991 | 285 |
| 22 | Demographic and clinical features of neuromyelitis optica: A review | Multiple Sclerosis Journal | 2015 | 278 |
| 23 | A Mutation in the Dimerization Domain of Filamin C Causes a Novel Type of Autosomal Dominant Myofibrillar Myopathy | American Journal of Human Genetics | 2005 | 268 |
| 24 | Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery | 2019 | 265 |
| 25 | Myelin-oligodendrocyte glycoprotein antibody-associated disease | Lancet Neurology, The | 2021 | 261 |
| 26 | Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand | Neurology | 2003 | 252 |
| 27 | The glutamate antagonist Riluzole suppresses intracortical facilitation | Journal of Neural Transmission | 1997 | 237 |
| 28 | Six months of dance intervention enhances postural, sensorimotor, and cognitive performance in elderly without affecting cardio-respiratory functions | Frontiers in Aging Neuroscience | 2013 | 235 |
| 29 | Transcranial brain parenchyma sonography in movement disorders: State of the art | Ultrasound in Medicine and Biology | 2007 | 234 |
| 30 | Structural Brain Anomalies and Chronic Pain: A Quantitative Meta-Analysis of Gray Matter Volume | Journal of Pain | 2013 | 233 |
| 31 | Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis | Clinical Drug Investigation | 2010 | 223 |
| 32 | Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) | Annals of Neurology | 2003 | 222 |
| 33 | Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab | Multiple Sclerosis Journal | 2012 | 220 |
| 34 | Gut Microbiota–Dependent Trimethylamine N -Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes | Arteriosclerosis, Thrombosis, and Vascular Biology | 2018 | 219 |
| 35 | Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients | Annals of Neurology | 2016 | 218 |
| 36 | Shifts in cortical representations predict human discrimination improvement | Proceedings of the National Academy of Sciences of the United States of America | 2001 | 217 |
| 37 | S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction | Stroke | 1997 | 215 |
| 38 | Functional Imaging of Perceptual Learning in Human Primary and Secondary Somatosensory Cortex | Neuron | 2003 | 214 |
| 39 | Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation | Brain | 2010 | 212 |
| 40 | Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder | JAMA Neurology | 2015 | 206 |
| 41 | MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome | Journal of Neuroinflammation | 2016 | 202 |
| 42 | Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study | European Journal of Neurology | 2006 | 195 |
| 43 | Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness | Practical Neurology | 2018 | 195 |
| 44 | Repetitive transcranial magnetic stimulation of the motor cortex attenuates pain perception in complex regional pain syndrome type I | Neuroscience Letters | 2004 | 191 |
| 45 | Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease | Neuroscience Letters | 2003 | 190 |
| 46 | Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy | JAMA Neurology | 2013 | 188 |
| 47 | Impacts of microbiome metabolites on immune regulation and autoimmunity | Immunology | 2018 | 185 |
| 48 | Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis | Brain | 2010 | 180 |
| 49 | Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society | Journal of Neurology | 2016 | 179 |
| 50 | The prevalence of primary headache disorders in Russia: A countrywide survey | Cephalalgia | 2012 | 176 |
